This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. advanced 4.8% to $6.54 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.1% to 15,603.26 and the Dow Jones Industrial Average falling 0.9% to 37,965.60.
This was the stock's second consecutive day of gains.
Novavax Inc. closed 72.6% short of its 52-week high of $23.86, which the company reached on June 6th.
The stock outperformed some of its competitors, as Johnson & Johnson fell 1.7% to $150.62, Pfizer Inc. fell 1.5% to $22.63, and Merck & Co. Inc. fell 0.36% to $81.18.
Trading volume totaled 7.5 million, compared to the 50-day average of 4.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 07, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。